Health in Germany

Welcome to Med-Kolleg - Health in Germany

This Health-Provider-Directory is designed to help doctors and other users to find out information on all aspects of the German health market.
We also refer international travelers requiring medical assistance to qualified doctors or specialists.

Med Kolleg is a health portal with general medicine and health topics. We have search facilities that allows you to find a hospital / clinic or practitioner in Germany from our database (physicians in Germany / hospitals in Germany). Med-Kolleg is completely independent from German insurances, hospitals and doctors.

Please note that general medical information - as provided on this website - does not replace visiting a physician or a medical emergency service, only a physician can assess the individual situation of your health.

Arztsuche

The German Health Care System

The German health care system dates back to 1883, when nationwide health insurance became compulsory. The German health care system has the reputation of being one of the best in the world. Medical facilities are equipped with the latest technology, an extensive network of hospitals and doctors covers even the remotest areas of Germany. Doctors are highly qualified with a thorough education as well as a high level of qualification amongst medical staff.
Read more about the German Health System

Arztverzeichnis

German Health Insurance Schemes

Health insurance in Germany is a part of the social security system.
There are two types of German Health Insurance Schemes - the State Health Insurance and the Private Health Insurance. 88 percent belong to a statutory health scheme and around nine percent are privately insured. Read more...

Health News Germany

2010-04-06:
Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban
Tokyo, April 6, 2010 ( PRN/ots ) - Daiichi Sankyo Company, Limited announced today that it has submitted a New Drug Application to the Ministry of Health, Labor and Welfare in Japan seeking approval of the anticoagulant, edoxaban, for the prevention of venous thromboembolism ( VTE ) after (...) Read more...

2008-05-15:
Landmark ATHENA Study Findings With Multaq( R )( dronedarone ) Show 24 Prozent Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
Paris ( PRN/ots ) - Sanofi - aventis ( EURONEXT: SAN and NYSE: SNY ) announced today that findings from the landmark ATHENA study showed that Multaq( R ) ( dronedarone ), a potential therapy for the treatment of patients with atrial fibrillation or atrial flutter, decreased the risk of cardiovascular hospitalisations or (...) Read more...

2008-07-09:
Industry Leaders Select Resverlogix's RVX - 208 Among Top 10 Most Promising Drugs
Calgary, Canada ( PRN/ots ) - Resverlogix Corp's ( "Resverlogix" or the "Company" ) ( TSX:RVX ) novel lead ApoA - I drug candidate, RVX - 208 has been selected as one of the top 10 most promising cardiovascular disease ( CVD ) drugs available for strategic partnering by an independent committee assembled (...) Read more...

2010-04-30:
Pieris Announces Positive Preclinical Data on c - Met Anticalin Drug Program
Freising - Weihenstephan ( na Originaltextservice ) - Novel Approach with PRS - 110 Shows Dose - dependent Response in Cancer Model Pieris AG announced today preclinical data for its proprietary PRS - 110 Anticalin" compound, which targets the c - Met receptor, demonstrating a dose - dependant reduction of (...) Read more...

2007-09-28:
Eisai Announce Establishment of New Pharmaceutical Marketing Subsidiary in Belgium
London ( PRN/ots ) - - For the Attention of Business and Healthcare Editors Eisai Co., Ltd. ( Headquarters: Tokyo, President & CEO: Haruo Naito ) announced today that the Company established its pharmaceutical marketing subsidiary, Eisai SA/NV in Belgium. Eisai SA/NV is owned by (...) Read more...

2007-02-06:
Abbott to Initiate First Study to Evaluate XIENCE( TM ) V Everolimus Eluting Coronary Stent System in Treatment of Women With Cardiovascular Disease
Abbott Park, Illinois ( PRN/ots ) - - First - of - its - Kind Study Designed to Learn More About Cardiovascular Disease in Women Abbott today announced plans to initiate the world's first drug - eluting stent clinical trial solely in women. The SPIRIT WOMEN trial will aim (...) Read more...

2007-06-27:
Isotechnika Achieves Full Enrolment for ISA247 Phase 2b Kidney Transplant Trial
Edmonton, Canada ( PRN/ots ) - Isotechnika Inc. ( TSX:ISA ) announced today the enrolment of the last patient in its Phase 2b trial assessing ISA247 for the prevention of kidney graft rejection following transplantation. Of the 332 patients enrolled, 148 patients have already completed the required (...) Read more...

2006-05-21:
Two Thirds of Family Doctors Believe COPD will be the Leading Cause of Death in 2020
San Diego, California ( PRN/ots ) - - For Accredited International Healthcare Journalists Only - Management of Exacerbations `Crucial' to Reduce COPD Mortality Survey results from the `Time to Live' report, presented today at the American Thoracic Society International Congress, show over two thirds of (...) Read more...

2009-05-27:
Boehringer Ingelheim and the World Stroke Organization Announce Partnership in the World Stroke Academy
Ingelheim, Germany ( PRN/ots ) - - For Healthcare Media Outside the U.S.A., Canada, and Japan Boehringer Ingelheim announced today that it will become the founding sponsor of the World Stroke Academy, a novel training initiative for stroke professionals being developed by the World Stroke (...) Read more...

2007-11-04:
Daiichi Sankyo, Lilly Announce New Prasugrel Head - to - Head Phase III Study Against Clopidogrel
Tokyo and Indianapolis, November 4 ( PRN/ots ) - - Duke Clinical Research Institute to lead multinational study with investigational compound; will include 10,000 medically managed patients with acute coronary syndrome A large Phase III clinical trial is anticipated to begin in the second quarter (...) Read more...

Surveys / Reports

Surveys / Reports

Notifiable Disease Surveillance and Practicing Physicians
Primary care physicians in Germany are essential participants in infectious disease surveillance through mandatory reporting.
In 2001, a new infectious disease control law (IfSG) was implemented in Germany. Most diseases are to be reported to the local county (Landkreis) health department from where they are reported by the state (Land) to the national surveillance institute (Robert Koch Institute). The IfSG also introduced national case definitions for notifiable diseases. The aim of this study was to identify the needs and attitudes of primary care physicians towards public health surveillance.
These issues were investigated in a questionnaire survey among 8,550 randomly sampled physicians in Germany in 2001.
» Krause G, Ropers G, Stark K. Notifiable disease surveillance and practicing physicians. Emerg Infect Dis [serial on the Internet]. 2005 Mar

Latest Entries / Latest Changes

Hospitals: latest entries / changes:

Vivantes Klinikum Neukölln Clinic für Kinder- and Jugendpsychiatrie, psychotherapy and Psychosomatik
Vivantes Klinikum Neukölln
12351 Berlin Neukölln (Berlin)
(changed: 2013-11-19)
Klinikum Delmenhorst gGmbH regular hospital for acute cases
Klinikum Delmenhorst gGmbH
27753 Delmenhorst (Lower Saxony)
(changed: 2011-12-25)

3330 entries in clinics directory.

DocSearch: latest entries / changes:

Dr. med. Xenia Burchardt
Dr. med. Xenia Burchardt
50935 Köln (North Rhine-Westphalia)
(changed: 2013-09-12)
Gemeinschaftspraxis Dipl.med. Karin Fronert u. Dr. med. Christian Kröner
Gemeinschaftspraxis Dipl.med. Karin Fronert u. Dr. med. Christian Kröner
89233 Neu-Ulm Jedelhausen (Bavaria)
(changed: 2013-08-23 )

Dentist Search: latest entries / changes:

Dr. med. dent. A.G. Laja
Dr. med. dent. A.G. Laja
40221 Düsseldorf Karlstadt / Altstadt (Nordrhein-Westfalen)
(changed: 2014-10-04)
Cornelia Beuschel
Cornelia Beuschel
Wilhelmshaven Nordhafen (Niedersachsen)
(changed: 2013-10-24 )